Erratum to: Diabetologia
DOI 10.1007/s00125-010-1702-3
Unfortunately, ‘Å. Sjöholm’ was spelt incorrectly in the author list on the original version.
In addition, the following text was omitted from the Duality of interest section: Å. Sjöholm has received lecture fees and honoraria for advisory boards from Eli Lilly, Merck, NovoNordisk, sanofi-aventis, Novartis and GlaxoSmithKline. R. Carmena has received lecture fees and honoraria for advisory boards from MSD, Pfizer, AstraZeneca and Takeda.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at http://dx.doi.org/10.1007/s00125-010-1702-3.
Rights and permissions
About this article
Cite this article
Schernthaner, G., Barnett, A.H., Betteridge, D.J. et al. Erratum to: Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis. Diabetologia 53, 1813 (2010). https://doi.org/10.1007/s00125-010-1797-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00125-010-1797-6